Related Experiment Video
Updated: Jan 31, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on
A J A T Braat1, S C Kappadath2, H Ahmadzadehfar3
1Department of Radiology and Nuclear Medicine, Imaging Division, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. a.j.a.t.braat@umcutrecht.nl.
Purpose:
Radioembolization of liver metastases of neuroendocrine neoplasms (NEN) has shown promising results; however, the current literature is of limited quality. A large international, multicentre retrospective study was designed to address several shortcomings of the current literature.
Materials:
244 NEN patients with different NEN grades were included.
Methods:
Primary outcome parameters were radiologic response 3 and 6 months after treatment according to RECIST 1.1 and mRECIST. Secondary outcome parameters included clinical response, clinical and biochemical toxicities.
Results:
Radioembolization resulted in CR in 2%, PR in 14%, SD in 75% and PD 9% according to RECIST 1.1 and in CR in 8%, PR in 35%, SD in 48% and PD in 9% according to mRECIST. Objective response rates improved over time in 20% and 26% according to RECIST 1.1. and mRECIST, respectively. Most common new grade 3-4 biochemical toxicity was lymphocytopenia (6.7%). No unexpected clinical toxicities occurred. Radioembolization-specific complications occurred in < 4%. In symptomatic patients, improvement and resolution of symptoms occurred in 44% and 34%, respectively. Median overall survival from first radioembolization was 3.7, 2.7 and 0.7 years for G1, G2 and G3, respectively. Objective response is independent of NEN grade or primary tumour origin. Significant prognostic factors for survival were NEN grade/Ki67 index, ≥ 75% intrahepatic tumour load, the presence of extrahepatic disease and disease control rate according to RECIST 1.1.
Conclusion:
Safety and efficacy of radioembolization in NEN patients was confirmed with a high disease control rate of 91% in progressive patients and alleviation of NEN-related symptoms in 79% of symptomatic patients.
Level Of Evidence:
4.
Insights
Radioembolization is a safe and effective treatment for neuroendocrine neoplasm (NEN) liver metastases, achieving a 91% disease control rate and symptom alleviation in 79% of patients. This study confirms its efficacy in improving outcomes for NEN patients.
Area of Science:
- Oncology
- Radiology
- Hepatology
Background:
- Neuroendocrine neoplasms (NEN) with liver metastases often have limited treatment options.
- Radioembolization shows promise, but high-quality evidence is scarce.
Purpose of the Study:
- To evaluate the safety and efficacy of radioembolization for liver metastases in neuroendocrine neoplasms (NEN).
- To address limitations in current literature regarding radioembolization in NEN patients.
Main Methods:
- A large, international, multicentre retrospective study included 244 NEN patients with varying NEN grades.
- Radiologic response (RECIST 1.1, mRECIST) and clinical outcomes were assessed at 3 and 6 months.
- Toxicity, symptom response, and overall survival were secondary endpoints.
Main Results:
- Objective response rates were 16% (RECIST 1.1) and 43% (mRECIST), with disease control rates of 91%.
- Median overall survival varied by grade: 3.7 years (G1), 2.7 years (G2), and 0.7 years (G3).
- Symptom improvement/resolution occurred in 79% of symptomatic patients; toxicity was generally low.
Conclusions:
- Radioembolization is a safe and effective treatment for NEN liver metastases, demonstrating high disease control and symptom relief.
- NEN grade/Ki67 index, tumor burden, and extrahepatic disease are significant prognostic factors for survival.
Related Concept Videos
Internal Energy
Internal Energy
Internal Receptors
Self-Efficacy
International System of Units
Prefixes are used to define both larger and smaller quantities in the SI system. For example, milli, micro, and nano define smaller quantities, while kilo, mega, and giga are used to define...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...

